| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway | Sawanyawisuth, K. Silsirivanit, A. Phoomak, C. Wongkham, C. Okada, S. Wongkham, S. |
2019 | ||||
| 2. | Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight. | Detarya, M Lert-Itthiporn, W Mahalapbutr, P Klaewkla, M Sorin, S Sawanyawisuth, K Silsirivanit, A Seubwai, W Wongkham, C Araki, N Wongkham, S |
2022 | ||||
| 3. | HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner | Sorin, S Kubota, S Hamidi, S Yokomizo-Nakano, T Vaeteewoottacharn, K Wongkham, S Waraasawapati, S Pairojkul, C Bai, J Morii, M Sheng, G Sawanyawisuth, K Sashida, G |
2022 | ||||
| 4. | Overexpression of HMGN3 nucleosome binding protein is associated with tumor invasion and TGF-β expression in cholangiocarcinoma | Sorin, S. Pokaew, N. Vaeteewoottacharn, K. Waraasawapati, S. Pairojkul, C. Sashida, G. Sawanyawisuth, K. |
2022 | ||||
| 5. | Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs | Yokomizo-Nakano, T. Hamashima, A. Kubota, S. Bai, J. Sorin, S. Sun, Y. Kikuchi, K. Iimori, M. Morii, M. Kanai, A. Iwama, A. Huang, G. Kurotaki, D. Takizawa, H. Matsui, H. Sashida, G. |
2023 | ||||
| 6. | γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. | Saengboonmee, C Sorin, S Sangkhamanon, S Chomphoo, S Indramanee, S Seubwai, W Thithuan, K Chiu, CF Okada, S Gingras, MC Wongkham, S |
2023 | ||||
| 7. | High glucose enhances the aggressiveness of lung adenocarcinoma via activating epidermal growth factor receptor/signal transducer and activator of transcription 3 pathways. | Sorin, S Zhou, Y Thithuan, K Khawkhiaw, K Zeng, F Ruangpratyakul, T Chomphoo, S Seubwai, W Wongkham, S Saengboonmee, C |
2023 | ||||
| 8. | Hyperglycemia Alters -GlcNAcylation Patterns of Hepatocytes in Mice Treated With Hepatoxic Carcinogen. | Chomphoo, S Kunprom, W Thithuan, K Sorin, S Khawkhiaw, K Kamkaew, A Phoomak, C Chiu, CF Saengboonmee, C |
2023 | ||||
| 9. | Hyperglycemia Alters O-GlcNAcylation Patterns of Hepatocytes in Mice Treated with Hepatoxic Carcinogen | Chomphoo, S. Kunprom, W. Thithuan, K. Sorin, S. Khawkhiaw, K. Kamkaew, A. Phoomak, C. Chiu, C.F. |
2023 | ||||
| 10. | Advancing Age May Decrease Mitochondrial Activity in Cumulus Cells | Jitngamsujarit, S. Salang, L. Saengboonmee, C. Sorin, S. Thithuan, K. Pongsritasana, T. Sukkasame, S. |
2024 | ||||
| 11. | CDKN3 acts as a tumor promoter enhancing proliferation of cholangiocarcinoma cells | Waenphimai, O. Thamrongwaranggoon, U. Kidoikhammouan, S. Sorin, S. Klinhom-on, N. |
2024 | ||||
| 12. | Involvement of interleukin-1β in high glucose-activated proliferation of cholangiocarcinoma. | Khawkhiaw, K Chomphoo, S Kunprom, W Thithuan, K Sorin, S Yueangchantuek, P Chiu, CF Umezawa, K Panaampon, J Okada, S Wongkham, S Saengboonmee, C |
2024 | ||||
| 13. | Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. | Trakoonsenathong, R Kunprom, W Aphivatanasiri, C Yueangchantuek, P Pimkeeree, P Sorin, S Khawkhiaw, K Chiu, CF Okada, S Wongkham, S Saengboonmee, C |
2024 | ||||
| 14. | Passifetilactones A-E, Fatty Acid Lactones from the Fruit and Flowers of with Cytotoxic Activity. | Ponsuwan, K Nathabumroong, S Lekphrom, R Sorin, S Saengboonmee, C Senawong, T Tontapha, S Schevenels, FT |
2024 | Count | 7 | 9 | 1 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway | Sawanyawisuth, K. Silsirivanit, A. Phoomak, C. Wongkham, C. Okada, S. Wongkham, S. |
2019 |
Scientific Reports 1 (9), pp. |
||||||||
| 2. | HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner | Sorin, S. Vaeteewoottacharn, K. Wongkham, S. Waraasawapati, S. Pairojkul, C. Sawanyawisuth, K. |
2022 |
FASEB Journal 7 (36), pp. |
||||||||
| 3. | Overexpression of HMGN3 nucleosome binding protein is associated with tumor invasion and TGF-β expression in cholangiocarcinoma | Sorin, S. Pokaew, N. Vaeteewoottacharn, K. Waraasawapati, S. Pairojkul, C. Sashida, G. Sawanyawisuth, K. |
2022 |
ScienceAsia 5 (48), pp. 518-523 |
||||||||
| 4. | Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs | Yokomizo-Nakano, T. Hamashima, A. Kubota, S. Bai, J. Sorin, S. Sun, Y. Kikuchi, K. Iimori, M. Morii, M. Kanai, A. Iwama, A. Huang, G. Kurotaki, D. Takizawa, H. Matsui, H. Sashida, G. |
2023 |
Journal of Experimental Medicine 7 (220), pp. |
||||||||
| 5. | Hyperglycemia Alters O-GlcNAcylation Patterns of Hepatocytes in Mice Treated with Hepatoxic Carcinogen | Chomphoo, S. Kunprom, W. Thithuan, K. Sorin, S. Khawkhiaw, K. Kamkaew, A. Phoomak, C. Chiu, C.F. |
2023 |
In Vivo 2 (37), pp. 685-695 |
||||||||
| 6. | Advancing Age May Decrease Mitochondrial Activity in Cumulus Cells | Jitngamsujarit, S. Salang, L. Saengboonmee, C. Sorin, S. Thithuan, K. Pongsritasana, T. Sukkasame, S. |
2024 |
Journal of Clinical Medicine 10 (13), pp. |
||||||||
| 7. | CDKN3 acts as a tumor promoter enhancing proliferation of cholangiocarcinoma cells | Waenphimai, O. Thamrongwaranggoon, U. Kidoikhammouan, S. Sorin, S. Klinhom-on, N. |
2024 |
ScienceAsia 6 (50), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway. | Indramanee, S Sawanyawisuth, K Silsirivanit, A Dana, P Phoomak, C Kariya, R Klinhom-On, N Sorin, S Wongkham, C Okada, S Wongkham, S |
2019 |
Scientific reports 1 (9), pp. 17266 |
|
| 2. | HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner. | Sorin, S Kubota, S Hamidi, S Yokomizo-Nakano, T Vaeteewoottacharn, K Wongkham, S Waraasawapati, S Pairojkul, C Bai, J Morii, M Sheng, G Sawanyawisuth, K Sashida, G |
2022 |
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 7 (36), pp. e22345 |
|
| 3. | Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight. | Detarya, M Lert-Itthiporn, W Mahalapbutr, P Klaewkla, M Sorin, S Sawanyawisuth, K Silsirivanit, A Seubwai, W Wongkham, C Araki, N Wongkham, S |
2022 |
American journal of cancer research 9 (12), pp. 4140-4159 |
|
| 4. | High glucose enhances the aggressiveness of lung adenocarcinoma via activating epidermal growth factor receptor/signal transducer and activator of transcription 3 pathways. | Sorin, S Zhou, Y Thithuan, K Khawkhiaw, K Zeng, F Ruangpratyakul, T Chomphoo, S Seubwai, W Wongkham, S Saengboonmee, C |
2023 |
The Journal of nutritional biochemistry (), pp. 109399 |
|
| 5. | γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. | Saengboonmee, C Sorin, S Sangkhamanon, S Chomphoo, S Indramanee, S Seubwai, W Thithuan, K Chiu, CF Okada, S Gingras, MC Wongkham, S |
2023 |
World journal of gastroenterology 28 (29), pp. 4416-4432 |
|
| 6. | Hyperglycemia Alters -GlcNAcylation Patterns of Hepatocytes in Mice Treated With Hepatoxic Carcinogen. | Chomphoo, S Kunprom, W Thithuan, K Sorin, S Khawkhiaw, K Kamkaew, A Phoomak, C Chiu, CF Saengboonmee, C |
2023 |
In vivo (Athens, Greece) 2 (37), pp. 685-695 |
|
| 7. | Passifetilactones A-E, Fatty Acid Lactones from the Fruit and Flowers of with Cytotoxic Activity. | Ponsuwan, K Nathabumroong, S Lekphrom, R Sorin, S Saengboonmee, C Senawong, T Tontapha, S Schevenels, FT |
2024 |
Journal of natural products 6 (87), pp. 1652-1659 |
|
| 8. | Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. | Trakoonsenathong, R Kunprom, W Aphivatanasiri, C Yueangchantuek, P Pimkeeree, P Sorin, S Khawkhiaw, K Chiu, CF Okada, S Wongkham, S Saengboonmee, C |
2024 |
Scientific reports 1 (14), pp. 13726 |
|
| 9. | Involvement of interleukin-1β in high glucose-activated proliferation of cholangiocarcinoma. | Khawkhiaw, K Chomphoo, S Kunprom, W Thithuan, K Sorin, S Yueangchantuek, P Chiu, CF Umezawa, K Panaampon, J Okada, S Wongkham, S Saengboonmee, C |
2024 |
Translational gastroenterology and hepatology (9), pp. 36 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway | Somsiri Indramanee Kanlayanee Sawanyawisuth Atit Silsirivanit Paweena Dana Chatchai Phoomak Ryusho Kariya Nathakan Klinhom-On Supannika Sorin Chaisiri Wongkham Seiji Okada Sopit Wongkham |
2019 |
SCIENTIFIC REPORTS (9.0), pp. |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|